{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:24:01Z","timestamp":1790886241573,"version":"4.1.0"},"reference-count":63,"publisher":"Cambridge University Press (CUP)","issue":"5","license":[{"start":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T00:00:00Z","timestamp":1173312000000},"content-version":"unspecified","delay-in-days":311,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Nutr"],"published-print":{"date-parts":[[2006,5]]},"abstract":"<jats:p>Policosanol is a mixture of higher aliphatic primary alcohols that is extracted from purified sugar cane wax or a variety of other plant sources, and has been shown to have beneficial effects on serum lipid concentrations. The objective of this study was to investigate the effects of a policosanol supplement (Octa-60) on lipid profiles of hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects. Nineteen hypercholesterolaemic and familial hypercholesterolaemic subjects completed this randomised, placebo-controlled, double-blind study. The subjects received either a daily dose of 20 mg policosanol or placebo for 12 weeks. After a wash-out period of 4 weeks, the interventions were crossed over. Lipid levels were measured at baseline and at the end of each intervention period. No significant differences in total cholesterol and LDL-cholesterol from baseline to end or between policosanol and placebo were seen in the hypercholesterolaemic or familial hypercholesterolaemic groups. There were small reductions in total cholesterol and LDL-cholesterol from baseline to end in the hypercholesterolaemic group, but these changes did not differ significantly from the changes with the placebo, indicating that the observed decrease in cholesterol in the policosanol group was not due to the specific effect of policosanol treatment. The differences in response may be ascribed to the differences in composition of the higher aliphatic primary alcohols in the previously used products, compared with the local policosanol supplement. An intake of 20 mg\/d policosanol for 12 weeks had no significant effect on serum lipid levels in hypercholesterolaemic and heterozygous familial hypercholesterolaemic patients when compared with placebo intake.<\/jats:p>","DOI":"10.1079\/bjn20061715","type":"journal-article","created":{"date-parts":[[2006,4,11]],"date-time":"2006-04-11T21:50:47Z","timestamp":1144792247000},"page":"968-975","source":"Crossref","is-referenced-by-count":58,"title":["Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects"],"prefix":"10.1017","volume":"95","author":[{"given":"A.","family":"Greyling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"De Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Oosthuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Jerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2007,3,8]]},"reference":[{"key":"S0007114506001267_ref059","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2003.01070.x"},{"key":"S0007114506001267_ref036","doi-asserted-by":"publisher","DOI":"10.1177\/153537020422900301"},{"key":"S0007114506001267_ref051","first-page":"S69","article-title":"Lack of effect of sugar cane and sunflower seed policosanols on plasma cholesterol in rabbits","volume":"13","author":"Murphy","year":"2004","journal-title":"Asia Pac J Clin Nutr"},{"key":"S0007114506001267_ref043","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00044011-200121070-00004","article-title":"Effects of policosanol on lipid profile and cardiac events in older hypercholesterolaemic patients with coronary disease","volume":"21","author":"Mas","year":"2001","journal-title":"Clin Drug Invest"},{"key":"S0007114506001267_ref045","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(99)80024-1"},{"key":"S0007114506001267_ref057","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6866(1998)18:1<1::AID-TCM1>3.0.CO;2-K"},{"key":"S0007114506001267_ref023","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(99)80016-2"},{"key":"S0007114506001267_ref026","first-page":"89","article-title":"Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus","volume":"22","author":"Castano","year":"2002","journal-title":"Int J Clin Pharmacol Res"},{"key":"S0007114506001267_ref012","first-page":"105","article-title":"ffects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients","volume":"19","author":"Castano","year":"1999","journal-title":"Int J Clin Pharmacol Res"},{"key":"S0007114506001267_ref032","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(98)85030-3"},{"key":"S0007114506001267_ref034","doi-asserted-by":"publisher","DOI":"10.1089\/109662001300341707"},{"key":"S0007114506001267_ref017","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(97)80010-0"},{"key":"S0007114506001267_ref058","doi-asserted-by":"publisher","DOI":"10.1016\/0278-6915(94)90115-5"},{"key":"S0007114506001267_ref053","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(02)00192-2"},{"key":"S0007114506001267_ref060","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(95)06162-2"},{"key":"S0007114506001267_ref013","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(98)85033-9"},{"key":"S0007114506001267_ref037","first-page":"203","article-title":"Policosanol: a new treatment for cardiovascular disease?","volume":"7","author":"Janikula","year":"2002","journal-title":"Altern Med Rev"},{"key":"S0007114506001267_ref048","doi-asserted-by":"publisher","DOI":"10.1079\/BJN19970090"},{"key":"S0007114506001267_ref031","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200121020-00003"},{"key":"S0007114506001267_ref030","first-page":"117","article-title":"Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.","volume":"19","author":"Crespo","year":"1999","journal-title":"Int J Clin Pharmacol Res"},{"key":"S0007114506001267_ref018","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/56.3.M186"},{"key":"S0007114506001267_ref038","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2004.05.006"},{"key":"S0007114506001267_ref022","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200320020-00006"},{"key":"S0007114506001267_ref046","first-page":"253","article-title":"Effect of policosanol on the hepatic cholesterol biosynthesis of normocholesterolemic rats","volume":"29","author":"Menendez","year":"1996","journal-title":"Biol Res"},{"key":"S0007114506001267_ref040","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(00)80004-1"},{"key":"S0007114506001267_ref035","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2002.119997"},{"key":"S0007114506001267_ref055","first-page":"27","article-title":"Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment","volume":"14","author":"Pons","year":"1994","journal-title":"Int J Clin Pharmacol Res"},{"key":"S0007114506001267_ref014","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(00)80011-9"},{"key":"S0007114506001267_ref056","doi-asserted-by":"publisher","DOI":"10.1002\/tcm.1770140302"},{"key":"S0007114506001267_ref024","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2003.09.002"},{"key":"S0007114506001267_ref028","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2003.11.010"},{"key":"S0007114506001267_ref029","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(97)80077-X"},{"key":"S0007114506001267_ref025","doi-asserted-by":"publisher","DOI":"10.1016\/0011-393X(95)85034-1"},{"key":"S0007114506001267_ref010","first-page":"55","article-title":"Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia","volume":"22","author":"Castano","year":"2002","journal-title":"Int J Clin Pharmacol Res"},{"key":"S0007114506001267_ref001","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4274(94)90147-3"},{"key":"S0007114506001267_ref002","doi-asserted-by":"publisher","DOI":"10.1016\/0278-6915(95)00026-X"},{"key":"S0007114506001267_ref003","doi-asserted-by":"publisher","DOI":"10.1016\/0011-393X(95)85043-0"},{"key":"S0007114506001267_ref004","first-page":"205","article-title":"Cholesterol-lowering effects of policosanol in rabbits","volume":"27","author":"Arruzazabala","year":"1994","journal-title":"Biol Res"},{"key":"S0007114506001267_ref005","first-page":"134","article-title":"Effect of policosanol on hyperlipidemia and coronary heart disease in middle-aged patients.A 14-month pilot study","volume":"34","author":"Batista","year":"1996","journal-title":"Int J Clin Pharmacol Ther"},{"key":"S0007114506001267_ref006","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(97)80052-5"},{"key":"S0007114506001267_ref007","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(97)80053-7"},{"key":"S0007114506001267_ref008","first-page":"159","article-title":"A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia","volume":"15","author":"Canetti","year":"1995","journal-title":"Int J Clin Pharmacol Res"},{"key":"S0007114506001267_ref009","doi-asserted-by":"publisher","DOI":"10.1016\/0011-393X(95)85065-1"},{"key":"S0007114506001267_ref011","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200323100-00003"},{"key":"S0007114506001267_ref015","doi-asserted-by":"publisher","DOI":"10.2165\/00126839-200203030-00004"},{"key":"S0007114506001267_ref016","doi-asserted-by":"publisher","DOI":"10.3109\/09513590009167681"},{"key":"S0007114506001267_ref019","first-page":"43","article-title":"Effects of policosanol 20 versus 40 mg\/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study","volume":"21","author":"Castano","year":"2001","journal-title":"Int J Clin Pharmacol Res"},{"key":"S0007114506001267_ref020","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(01)80031-X"},{"key":"S0007114506001267_ref021","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(02)80033-9"},{"key":"S0007114506001267_ref027","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(96)80074-9"},{"key":"S0007114506001267_ref062","doi-asserted-by":"publisher","DOI":"10.1301\/nr.2003.nov.376-383"},{"key":"S0007114506001267_ref033","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"S0007114506001267_ref039","first-page":"1533","volume-title":"Cardiovascular disease.In:Modern nutrition in healthand disease","author":"McNamara","year":"1994"},{"key":"S0007114506001267_ref041","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780192627391.001.0001"},{"key":"S0007114506001267_ref042","first-page":"569","article-title":"Policosanol. Hypolipidemic antioxidant treatment of atherosclerosis","volume":"25","author":"Mas","year":"2000","journal-title":"Drugs Future"},{"key":"S0007114506001267_ref044","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70139-6"},{"key":"S0007114506001267_ref047","doi-asserted-by":"publisher","DOI":"10.1016\/S0188-4409(00)00265-4"},{"key":"S0007114506001267_ref049","first-page":"199","article-title":"Policosanol inhibits cholesterol biosynthesis and enhances low density lipoprotein processing in cultured human fibroblasts","volume":"27","author":"Menendez","year":"1994","journal-title":"Biol Res"},{"key":"S0007114506001267_ref050","first-page":"31","article-title":"Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women","volume":"21","author":"Mirkin","year":"2001","journal-title":"Int J Clin Pharmacol Res"},{"key":"S0007114506001267_ref052","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(97)80099-9"},{"key":"S0007114506001267_ref054","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(97)80074-4"},{"key":"S0007114506001267_ref061","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.3.393"},{"key":"S0007114506001267_ref063","doi-asserted-by":"publisher","DOI":"10.1007\/s11745-003-1047-3"}],"container-title":["British Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007114506001267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T19:32:30Z","timestamp":1586806350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007114506001267\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0007114506001267"],"URL":"https:\/\/doi.org\/10.1079\/bjn20061715","relation":{},"ISSN":["0007-1145","1475-2662"],"issn-type":[{"value":"0007-1145","type":"print"},{"value":"1475-2662","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}